Biological profile of a bioactive aortic substance (BAS), released by vessel rings from indomethacin-treated rats

The biological activity of a stable unknown material(s), generated by aortic rings (bioactive aortic substance= BAS) isolated from rats injected with a high dose of indomethacin, was explored on contractions of several smooth muscle preparations from normal rats and its effects compared with those e...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chaud, M.A., Shattner, M., González, E.T., Lazzari, M.A., Gimeno, M.F., Gimeno, A.L.
Formato: JOUR
Materias:
rat
Acceso en línea:http://hdl.handle.net/20.500.12110/paper_02621746_v22_n2_p211_Chaud
Aporte de:
id todo:paper_02621746_v22_n2_p211_Chaud
record_format dspace
spelling todo:paper_02621746_v22_n2_p211_Chaud2023-10-03T15:12:37Z Biological profile of a bioactive aortic substance (BAS), released by vessel rings from indomethacin-treated rats Chaud, M.A. Shattner, M. González, E.T. Lazzari, M.A. Gimeno, M.F. Gimeno, A.L. 6 oxoprostaglandin f1 alpha atropine cyproheptadine indometacin phentolamine propranolol prostacyclin animal cell bladder drug efficacy drug interaction muscle nonhuman priority journal rat small intestine smooth muscle contractility stomach vascular ring 6-Ketoprostaglandin F1 alpha Animals Aorta, Abdominal Aorta, Thoracic Culture Media Epoprostenol Female Indomethacin Injections, Subcutaneous Muscle Contraction Muscle, Smooth, Vascular Platelet Aggregation Rats Rats, Inbred Strains Animalia The biological activity of a stable unknown material(s), generated by aortic rings (bioactive aortic substance= BAS) isolated from rats injected with a high dose of indomethacin, was explored on contractions of several smooth muscle preparations from normal rats and its effects compared with those elicited by prostacyclin (PGI2) or by 6-keto-prostaglandin F1α. (6-k-PGF1α). The BAS evoked, as did PGI2 or 6-k-PGF1α, positive inotropism in strips from rat stomach, ileum and urinary bladder, but failed to influence uterine contractions as did prostacyclin or its non-enzymatic metabolite. When tested in rat aortic strips both, PGI2 and the BAS produced relaxation, whereas 6-k-PGF1α was not active. Moreover, lipid substances present in the incubates of aortic rings, were extracted and explored for effects on contractions of rat aortic strips and on arachidonate-evoked human platelet aggregation. These extracts were devoid of influence on both parameters. On the contrary, dried aqueous residues, after the lipid extraction of the supernatants of aortic ring incubates, exhibited human platelet antiaggregatory capacity as well as the ability to evoke positive and negative inotropism similar to those triggered by the BAS in different smooth muscle preparations. Experiments with BAS were also performed employing smooth muscle strips exposed to indomethacin, atropine, propranolol, phentolamine and cyproheptadine. The presence of these antagonists of several neuromodulators and of indomethacin failed to alter de BAS-induced inotropic capacity observed in controls. The findings suggest that the effects attributable to the BAS are not subserved by prostacyclin or other prostanoids, nor by acetylcholine, norepinephrine, histamine or 6-OH-tryptemine. © 1986. JOUR info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar http://hdl.handle.net/20.500.12110/paper_02621746_v22_n2_p211_Chaud
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic 6 oxoprostaglandin f1 alpha
atropine
cyproheptadine
indometacin
phentolamine
propranolol
prostacyclin
animal cell
bladder
drug efficacy
drug interaction
muscle
nonhuman
priority journal
rat
small intestine
smooth muscle contractility
stomach
vascular ring
6-Ketoprostaglandin F1 alpha
Animals
Aorta, Abdominal
Aorta, Thoracic
Culture Media
Epoprostenol
Female
Indomethacin
Injections, Subcutaneous
Muscle Contraction
Muscle, Smooth, Vascular
Platelet Aggregation
Rats
Rats, Inbred Strains
Animalia
spellingShingle 6 oxoprostaglandin f1 alpha
atropine
cyproheptadine
indometacin
phentolamine
propranolol
prostacyclin
animal cell
bladder
drug efficacy
drug interaction
muscle
nonhuman
priority journal
rat
small intestine
smooth muscle contractility
stomach
vascular ring
6-Ketoprostaglandin F1 alpha
Animals
Aorta, Abdominal
Aorta, Thoracic
Culture Media
Epoprostenol
Female
Indomethacin
Injections, Subcutaneous
Muscle Contraction
Muscle, Smooth, Vascular
Platelet Aggregation
Rats
Rats, Inbred Strains
Animalia
Chaud, M.A.
Shattner, M.
González, E.T.
Lazzari, M.A.
Gimeno, M.F.
Gimeno, A.L.
Biological profile of a bioactive aortic substance (BAS), released by vessel rings from indomethacin-treated rats
topic_facet 6 oxoprostaglandin f1 alpha
atropine
cyproheptadine
indometacin
phentolamine
propranolol
prostacyclin
animal cell
bladder
drug efficacy
drug interaction
muscle
nonhuman
priority journal
rat
small intestine
smooth muscle contractility
stomach
vascular ring
6-Ketoprostaglandin F1 alpha
Animals
Aorta, Abdominal
Aorta, Thoracic
Culture Media
Epoprostenol
Female
Indomethacin
Injections, Subcutaneous
Muscle Contraction
Muscle, Smooth, Vascular
Platelet Aggregation
Rats
Rats, Inbred Strains
Animalia
description The biological activity of a stable unknown material(s), generated by aortic rings (bioactive aortic substance= BAS) isolated from rats injected with a high dose of indomethacin, was explored on contractions of several smooth muscle preparations from normal rats and its effects compared with those elicited by prostacyclin (PGI2) or by 6-keto-prostaglandin F1α. (6-k-PGF1α). The BAS evoked, as did PGI2 or 6-k-PGF1α, positive inotropism in strips from rat stomach, ileum and urinary bladder, but failed to influence uterine contractions as did prostacyclin or its non-enzymatic metabolite. When tested in rat aortic strips both, PGI2 and the BAS produced relaxation, whereas 6-k-PGF1α was not active. Moreover, lipid substances present in the incubates of aortic rings, were extracted and explored for effects on contractions of rat aortic strips and on arachidonate-evoked human platelet aggregation. These extracts were devoid of influence on both parameters. On the contrary, dried aqueous residues, after the lipid extraction of the supernatants of aortic ring incubates, exhibited human platelet antiaggregatory capacity as well as the ability to evoke positive and negative inotropism similar to those triggered by the BAS in different smooth muscle preparations. Experiments with BAS were also performed employing smooth muscle strips exposed to indomethacin, atropine, propranolol, phentolamine and cyproheptadine. The presence of these antagonists of several neuromodulators and of indomethacin failed to alter de BAS-induced inotropic capacity observed in controls. The findings suggest that the effects attributable to the BAS are not subserved by prostacyclin or other prostanoids, nor by acetylcholine, norepinephrine, histamine or 6-OH-tryptemine. © 1986.
format JOUR
author Chaud, M.A.
Shattner, M.
González, E.T.
Lazzari, M.A.
Gimeno, M.F.
Gimeno, A.L.
author_facet Chaud, M.A.
Shattner, M.
González, E.T.
Lazzari, M.A.
Gimeno, M.F.
Gimeno, A.L.
author_sort Chaud, M.A.
title Biological profile of a bioactive aortic substance (BAS), released by vessel rings from indomethacin-treated rats
title_short Biological profile of a bioactive aortic substance (BAS), released by vessel rings from indomethacin-treated rats
title_full Biological profile of a bioactive aortic substance (BAS), released by vessel rings from indomethacin-treated rats
title_fullStr Biological profile of a bioactive aortic substance (BAS), released by vessel rings from indomethacin-treated rats
title_full_unstemmed Biological profile of a bioactive aortic substance (BAS), released by vessel rings from indomethacin-treated rats
title_sort biological profile of a bioactive aortic substance (bas), released by vessel rings from indomethacin-treated rats
url http://hdl.handle.net/20.500.12110/paper_02621746_v22_n2_p211_Chaud
work_keys_str_mv AT chaudma biologicalprofileofabioactiveaorticsubstancebasreleasedbyvesselringsfromindomethacintreatedrats
AT shattnerm biologicalprofileofabioactiveaorticsubstancebasreleasedbyvesselringsfromindomethacintreatedrats
AT gonzalezet biologicalprofileofabioactiveaorticsubstancebasreleasedbyvesselringsfromindomethacintreatedrats
AT lazzarima biologicalprofileofabioactiveaorticsubstancebasreleasedbyvesselringsfromindomethacintreatedrats
AT gimenomf biologicalprofileofabioactiveaorticsubstancebasreleasedbyvesselringsfromindomethacintreatedrats
AT gimenoal biologicalprofileofabioactiveaorticsubstancebasreleasedbyvesselringsfromindomethacintreatedrats
_version_ 1782025922438758400